Esketamine clinics with supervised monitoring

Domain VII · Transpersonal, psychedelic & altered states · 2019 · USA

What it is

An esketamine clinic is a service model, not a psychotherapy. Esketamine (brand SPRAVATO, Janssen / Johnson & Johnson) is a prescription antidepressant given only in a medically supervised, certified healthcare setting, where a healthcare provider directly observes the patient during and after each…

Format

• Format: psychiatric assessment by the prescriber; medical review by medical staff; structured measures.
• Format: one or more visits. The trial integration arm uses brief, manualised preparation sessions given by trained clinicians; the manual is not named publicly.

Who practises it, and how they are trained or regulated

• What it is. An esketamine clinic is a service model, not a psychotherapy. Esketamine (brand SPRAVATO, Janssen / Johnson & Johnson) is a prescription antidepressant given only in a medically supervised, certified healthcare setting, where a healthcare provider directly observes the patient during and after each treatment session until the patient is clinically stable and ready to leave. Neither the label nor the…
• Where a psychotherapist fits. A psychotherapist may (a) refer and co-treat a client receiving esketamine elsewhere, (b) work inside a certified clinic delivering preparation, supportive presence and integration alongside the medical monitoring team, or (c) provide adjunctive psychotherapy scheduled around treatment sessions. Medical screening, administration, vital-sign monitoring and discharge decisions are the…
• Legal and regulatory status (as of the sources' dates).

Questions to explore with your client

• What drew you to it, and what are you hoping it will change?
• Is there physical contact? Was it explained beforehand, and do you feel free to say no or stop at any point?
• Does it involve any substance, plant preparation, remedy or supplement? Has your doctor or prescriber been told, especially about any medication you take?
• Does it involve intense or unusual breathing? Have you been told about the medical conditions for which that is not advised?
• Does it use a device, heat, cold, water or a physical procedure? Has a medical professional checked that it is safe for you?
• Who runs it, and what training or registration do they hold?
• What actually happens in a session or meeting, and how often?
• What does it cost, and is there pressure to commit to more?
• How do you feel afterwards, in the hours and days that follow?
• Does it fit with, or clash with, the work we do here?

What practitioners of it watch for

• the client settles, and at debrief describes the experience as manageable.
• shared spaces where other patients' distress or staff conversation intrudes; adjust seating, use screens or headphones.
• craving for the session state, minimising other substance use, or interest in obtaining ketamine outside the clinic (see 4.18).
• a client who hears only the hopeful parts. Ask them to repeat the driving rule and the observation requirement in their own words.
• the client can describe what may happen and their coping plan; anticipatory anxiety drops; at debrief they report feeling prepared.

When to involve someone else

• New or worsening physical symptoms, or advice to stop or change prescribed medication: involve the client's doctor or prescriber.
• Signs of coercion, isolation from family and friends, escalating costs or secrecy: discuss openly and consider safeguarding.
• A crisis or thoughts of suicide: follow your crisis protocol. In the US, call or text 988; in the UK and Ireland, Samaritans on 116 123.

Drawn automatically from the guide's own sections. Stay curious: neither endorse nor dismiss what the client values, and check anything that matters against the full guide and its sources. Not medical advice.